Biotech

All Articles

8 months after a $213M fundraise, gene editor Tome produces reduces

.After bring up $213 million in 2023-- one of the year's most extensive private biotech rounds-- Vol...

BioMarin develops officer team along with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and ...

Biopharma Q2 VC reached highest level because '22, while M&ampA reduced

.Equity capital backing in to biopharma rose to $9.2 billion across 215 handle the 2nd one-fourth of...

Bicara, Zenas look for IPOs to drive late-phase resources towards market

.Bicara Therapies and Zenas Biopharma have actually delivered clean catalyst to the IPO market with ...

Genentech to finalize cancer immunology study department

.Genentech will close its own cancer cells immunology analysis division, and also system head as wel...

Kezar drops sound cyst but to show its worth in phase 1 trial

.Kezar Lifestyle Sciences is actually falling its own unpromising phase 1 solid cyst medicine as the...

Acelyrin falls izokibep, lays off 3rd of workers

.Regardless of izokibep sustaining its own newly found winning streak in the facility, Acelyrin is n...

Rivus' period 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...

Ovid standstills preclinical work, IV system after soticlestat fall short

.Ovid Therapeutics already showed final month that it was trimming back its own head count as the co...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened up a $700 million R&ampD facility in the Boston ma Seaport, improving...